News

Bookmark and Share

ADDF-Harrington - Grant Opportunity for UK-based Pis

The Alzheimer's Drug Discovery Foundation (ADDF) and Harrington Discovery Institute provide funding and drug development support of research efforts that aim to treat or prevent Alzheimer’s disease, related dementias and cognitive-decline associated with aging. Each year up to two ADDF-Harrington Scholars are chosen. The award includes:

  • Two-year grant
  • Funding up to $600,000
  • Drug development expertise and project management support
  • A personalized team of drug developers and project manager for each award recipient
  • Expert business, commercialization and clinical development advice
  • Regulatory assistance
  • Intellectual property (IP) review and advice
  • Assistance identifying and securing additional financial support based on project needs
  • Further information here

  • Call Opens for Letters of Intent (LOI)
    June 1, 2022
  • LOI Submission Deadline
    July 18, 2022
  • Full Application Deadline for those Invited
    October 24, 2022
  • Announce 2022 ADDF-Harrington Scholars
    April 2023

Posted on 06/06/2022

Further news

Go to the news index page.